Evaluation of vitreoretinal interface changes in patients receiving intravitreal anti-VEGF therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology
Link
http://link.springer.com/article/10.1007/s10792-017-0490-x/fulltext.html
Reference34 articles.
1. Rosenfeld P, Brown D, Heier J et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431
2. Brown D, Michels M, Kaiser P et al (2009) Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 116:57–65
3. Brown D, Nguyen Q, Marcus D et al (2013) Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials. Ophthalmology 120:2013–2022
4. Schmidt-Erfurth U, Lang G, Holz F et al (2014) Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema. Ophthalmology 121:1045–1053
5. Ozturk B, Kerimoglu H, Bozkurt B, Okudan S (2011) Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema. J Ocul Pharmacol Ther 27:373–377
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Central posterior hyaloidal fibrosis – A novel optical coherence tomography feature associated with choroidal neovascular membrane;American Journal of Ophthalmology Case Reports;2022-12
2. The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF;BMC Ophthalmology;2022-11-03
3. PROGRESSION OF PARTIAL POSTERIOR VITREOUS DETACHMENT OVER TIME;Retina;2021-07
4. Characteristics and surgical outcomes of rhegmatogenous retinal detachments that develop after intravitreal injections;Japanese Journal of Ophthalmology;2021-03-21
5. Effect of intravitreal anti-vascular endothelial growth factor administration on the vitreomacular interface and retinal morphology in eyes with neovascular age-related macular degeneration;Spektrum der Augenheilkunde;2020-11-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3